Lexicon Pharmaceuticals (LXRX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

LXRX is expected to report earnings to fall 6.18% to -15 cents per share on November 06

Lexicon Pharmaceuticals LXRX Stock Earnings Reports

Q3'24

Est.

$-0.16

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.20

Q4'23

Beat

by $0.02

Q3'23

Est.

$-0.21

The last earnings report on August 01 showed earnings per share of -17 cents, beating the estimate of -18 cents. With 2.82M shares outstanding, the current market capitalization sits at 578.39M.

View a ticker or compare two or three

Compare

LXRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LXRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in discovery and development of breakthrough treatments for human disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2445 Technology Forest Boulevard

Phone

+1 281 863-3000

Employees

285

Web

https://www.lexpharma.com